Table 2.

Complications and adverse events

Complication or event	Control (n = 11)	Fingolimod (n = 11)	P value
Complications
Deaths	0 (0)	0 (0)	1.00
Myocardial infarctions	0 (0)	0 (0)	1.00
Recurrent strokes	0 (0)	0 (0)	1.00
Cerebral hernia	0 (0)	0 (0)	1.00
Hemorrhage of digestive tract	0 (0)	0 (0)	1.00
Fever (>38 °C)	3 (27)	3 (27)	1.00
Event
All events
At least one adverse event	3 (27)	3 (27)	1.00
Any adverse event leading to discontinuation	0 (0)	0 (0)	1.00
Any serious adverse event	0 (0)	0 (0)	1.00
Frequent or special-interest adverse event
Suspected lung infection	3 (27)	3 (27)	1.00
Urinary tract infection	0 (0)	0 (0)	1.00
Herpes virus infection	0 (0)	0 (0)	1.00
Abnormal laboratory liver-function test	0 (0)	0 (0)	1.00
Gastrointestinal disorders	0 (0)	0 (0)	1.00
Leukopenia	0 (0)	0 (0)	1.00
Lymphopenia	0 (0)	0 (0)	1.00
Bradycardia	0 (0)	0 (0)	1.00
Atrioventricular block	0 (0)	0 (0)	1.00
Macular edema	0 (0)	0 (0)	1.00

Data are n (%).